Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Recombinant human chorionic gonadotropin - Ferring Pharmaceuticals

Next Previous
Drug Profile

Recombinant human chorionic gonadotropin - Ferring Pharmaceuticals

Alternative Names: FE-999302; Novarel

Latest Information Update: 29 Jul 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ferring Pharmaceuticals
  • Class Infertility therapies; Peptide hormones; Pituitary gonadotropins; Placental hormones
  • Mechanism of Action Chorionic gonadotropin stimulants; Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Infertility

Most Recent Events

  • 15 Jul 2024 Ferring Pharmaceuticals initiates a phase I Celestial-2 trial in Infertility in Spain (SC) (NCT06511791)
  • 14 Jun 2024 Ferrings Pharmaceutical initiates a phase 1b Celestial-1 trial in Infertility in Czech Republic (NCT06466486)
  • 09 Jan 2023 Ferring Pharmaceuticals withdraws the phase II TIFFANY trial in Infertility in Denmark, Spain and Czech Republic (SC) due to company's decision to close the project (NCT05571111)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top